87 related articles for article (PubMed ID: 11712678)
21. Detection of human papillomavirus and relevant tumor suppressors and oncoproteins in laryngeal tumors.
Manjarrez ME; Ocadiz R; Valle L; Pacheco C; Marroquin A; De la Torre C; Selman M; Gariglio P
Clin Cancer Res; 2006 Dec; 12(23):6946-51. PubMed ID: 17145812
[TBL] [Abstract][Full Text] [Related]
22. Use of fuzzy neural networks in modeling relationships of HPV infection with apoptotic and proliferation markers in potentially malignant oral lesions.
Campisi G; Di Fede O; Giovannelli L; Capra G; Greco I; Calvino F; Maria Florena A; Lo Muzio L
Oral Oncol; 2005 Nov; 41(10):994-1004. PubMed ID: 16129653
[TBL] [Abstract][Full Text] [Related]
23. [Diagnosis and treatment of oral precancerous lesions].
Sudbø J; Warloe T; Aamdal S; Reith A; Bryne M
Tidsskr Nor Laegeforen; 2001 Oct; 121(26):3066-71. PubMed ID: 11757442
[TBL] [Abstract][Full Text] [Related]
24. Biological indicators of aggressiveness in T1 ductal invasive breast cancer.
Bucci B; Carico E; Rinaldi A; Froio F; Puce YM; D'Agnano I; Vecchione A; Brunetti E
Anticancer Res; 2001; 21(4B):2949-55. PubMed ID: 11712792
[TBL] [Abstract][Full Text] [Related]
25. [Correlation between human papilloma virus infection in cervical lesions and expression of p53, p21 proteins and Ki-67].
Horikoshi M; Kina K; Ishi K; Izumi H; Kunii Y; Nojima M
Rinsho Byori; 2005 Jun; 53(6):494-8. PubMed ID: 16026074
[TBL] [Abstract][Full Text] [Related]
26. [Flow cytometry of cervical cell changes].
Lehtinen M; Paavonen J; Ylä-Outinen A; Romppanen U; Kulomaa P; Kallioniemi OP; Lehtinen T; Aine R; Lauslahti K; Vesterinen E
Duodecim; 1988; 104(7):517-24. PubMed ID: 3168838
[No Abstract] [Full Text] [Related]
27. Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions.
Cento V; Ciccozzi M; Ronga L; Perno CF; Ciotti M
J Med Virol; 2009 Sep; 81(9):1627-34. PubMed ID: 19626616
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus type 16 in tumor tissue of low-stage squamous carcinoma of the uterine cervix in relation to ploidy grade and prognosis.
Kenter GG; Cornelisse CJ; Jiwa NM; Aartsen EJ; Hermans J; Mooi W; Heintz AP; Fleuren GJ
Cancer; 1993 Jan; 71(2):397-401. PubMed ID: 8380752
[TBL] [Abstract][Full Text] [Related]
29. Nuclear DNA content and the number of Barr bodies in premalignant and malignant lesions of the uterine cervix.
Nishiya I; Ishizaki Y; Sasaki M
Acta Cytol; 1981; 25(4):407-11. PubMed ID: 6945007
[TBL] [Abstract][Full Text] [Related]
30. Nuclear texture: can it be used as a surrogate endpoint biomarker?
Palcic B
J Cell Biochem Suppl; 1994; 19():40-6. PubMed ID: 7823604
[TBL] [Abstract][Full Text] [Related]
31. Endpoint markers for clinical trials of chemopreventive agents derived from the properties of epithelial precancer (intraepithelial neoplasia) measured by computer-assisted image analysis.
Boone CW; Kelloff GJ
Cancer Surv; 1998; 32():133-47. PubMed ID: 10489626
[TBL] [Abstract][Full Text] [Related]
32. Correspondence re: Chieco P, Van Noorden C. Letter to the editor [in re Rubin EM, Derose PB, Cohen C. Comparative image cytometric DNA ploidy of liver cell dysplasia and hepatocellular carcinoma. Mod Pathol 1994;7:677]. Mod Pathol 1996;9:84-5.
Gschwendtner A; Mairinger T
Mod Pathol; 1997 Jan; 10(1):84-5. PubMed ID: 9021731
[No Abstract] [Full Text] [Related]
33. [Amplification and expression of HER-2 oncogene in precancerous stages and cancers of the endometrium].
Czerwenka KF; Heuss F; Zeillinger R; Hosmann JW; Wagner T; Manavi M; Jelincic D; Lu Y; Kubista E
Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():287-8. PubMed ID: 7906978
[No Abstract] [Full Text] [Related]
34. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix.
Heselmeyer K; Schröck E; du Manoir S; Blegen H; Shah K; Steinbeck R; Auer G; Ried T
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):479-84. PubMed ID: 8552665
[TBL] [Abstract][Full Text] [Related]
35. Spatial distribution of DNA ploidy in colorectal carcinoma.
Bigras G; Bonneau R; Dumont A
Anal Cell Pathol; 1994 Dec; 7(4):289-300. PubMed ID: 7696154
[TBL] [Abstract][Full Text] [Related]
36. [The problem of the ploidy reduction in carcinogenesis of the uterine cervix: numerical chromosome anomalies in carcinoma in situ (author's transl)].
Schüssler J; Dehnhard F; Breinl H
Arch Gynakol; 1977 Jul; 222(4):285-93. PubMed ID: 578101
[TBL] [Abstract][Full Text] [Related]
37. Genital warts and cervical cancer. VI. The relationship between aneuploid and polyploid cervical lesions.
Reid R; Fu YS; Herschman BR; Crum CP; Braun L; Shah KV; Agronow SJ; Stanhope CR
Am J Obstet Gynecol; 1984 Sep; 150(2):189-99. PubMed ID: 6089564
[TBL] [Abstract][Full Text] [Related]
38. Quantitative DNA patterns in human preneoplastic breast lesions.
Teplitz RL; Butler BB; Tesluk H; Min BH; Russell LA; Jensen HM; Hill LR
Anal Quant Cytol Histol; 1990 Apr; 12(2):98-102. PubMed ID: 2350391
[TBL] [Abstract][Full Text] [Related]
39. Estrogen and progesterone receptor, human papillomavirus, and DNA ploidy analysis in invasive carcinoma of the cervix in pregnancy.
Robertson DI; Paslawski D; Duggan MA; Stuart GC; Nation JG
Am J Clin Pathol; 1993 Jul; 100(1):18-21. PubMed ID: 8394046
[TBL] [Abstract][Full Text] [Related]
40. Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions.
Protrka Z; Arsenijevic S; Dimitrijevic A; Mitrovic S; Stankovic V; Milosavljevic M; Kastratovic T; Djuric J
Eur J Histochem; 2011 Mar; 55(1):e8. PubMed ID: 21556123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
